Validation of Heart Failure Events in the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) Participants Assigned to Doxazosin and Chlorthalidone

BACKGROUND: The Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) is a randomized, double-blind, active-controlled trial designed to compare the rate of coronary heart disease events in high-risk hypertensive participants initially randomized to a diuretic (chlorth...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Piller, Linda B, Davis, Barry R, Cutler, Jeffrey A, Cushman, William C, Wright, Jackson T, Williamson, Jeff D, Leenen, Frans HH, Einhorn, Paula T, Randall, Otelio S, Golden, John S, Haywood, L Julian
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2002
Teme:
Research
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC149403/
https://ncbi.nlm.nih.gov/pubmed/12459039
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1468-6708-3-10
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items